Ani Pharmaceuticals Inc (ANIP)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Finanzdaten der Ani Pharmaceuticals Inc-Aktie (ANIP)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	7.23% 211.37	197.12	190.57	148.33	138.04
Operating Expenses	15.53% 197.48	170.93	194.95	168.85	132.87
Benefits Costs and Expenses	13.39% 200.85	177.13	204.34	179.83	140.33
Costs And Expenses	15.53% 197.48	170.93	194.95	168.85	132.87
Depreciation and Amortization	1.70% 23.28	22.89	22.60	15.75	14.70
Operating Income/Loss	46.96% 13.89	26.19	-4.378	-20.52	5.169
Interest And Devidend Income	6.14% 2.784	2.623	-	-	-
Income/Loss From Continuing Operations Before Tax	47.34% 10.53	19.99	-13.76	-31.50	-2.287
Income Tax Expense/Benefit	54.11% 1.976	4.306	-3.486	-7.332	-
Income/Loss From Continuing Operations After Tax	45.48% 8.549	15.68	-10.28	-24.17	-2.287
Net Income/Loss	45.48% 8.549	15.68	-10.28	-24.17	-2.287
Preferred Stock Dividends And Other Adjustments	0.25% 0.407	0.406	0.406	0.406	0.407
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	1.16% 19.83	19.61	0.043	19.40	19.32
Diluted Average Shares	1.31% 20.31	20.05	0.043	19.40	19.32
Basic Earnings Per Share	47.14% 0.37	0.70	-0.55	-1.27	-0.14
Diluted Earnings Per Share	47.83% 0.36	0.69	-0.55	-1.27	-0.14
Undistributed Earnings/Loss Allocated To Participating Securities, Basic	47.63% 0.819	1.564	-	-	-
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	37.77% 1.226	1.97	0.406	0.406	0.407

HIMS

$45.46

3.18%

ELAN

$22.15

1.86%

RDY

$13.29

1.19%

VTRS

$10.36

0.00%

NBIX

$143.21

3.75%

UTHR

$445.43

1.79%